MAY 03, 2018 1:48 AM PDT

Treating Migraines with Less Side-Effects

WRITTEN BY: Nouran Amin

According to a 2013 Global Burden of Disease Study and the World Health Organization (WHO), migraine makes the list as the sixth highest cause worldwide for years lost due to disability.

Now, scientists have stumbled upon a side-effect free treatment option for chronic migraines. These side-effects that are usually accompanied with conventional treatments include fatigue, racing heartbeat, or nausea.

The discovered drug is erenumab which works against migraines to inhibit pain signals by targeting a receptor for calcitonin gene-related peptide (CGRP). According to the American Academy of Neurology, CGRP is responsible for the pain trsamiiosn. With erenumab, the drug works to inhint the nerves to which CGRP peptide binds, ebentiaull blocking the pain.

To test the effectiveness of the drug, investigators examined 246 people who are considered “more difficult to treat” noted by study author Uwe Reuter in a news release. The participants received injections of either 140 milligrams of erenumab or a placebo once every month for a total of three months.

“Our results show that people who thought their migraines were difficult to prevent may actually have hope of finding pain relief,” explains Uwe Reuter said, “More research is now needed to understand who is most likely to benefit from this new treatment.” However, one disadvantage from this study was that researchers evaluated patients over a three-month period.

Current treatment options for migraines include OTC counter NSAIDs or dedicated triptans. These treatment options come with their own side effects such as drowsiness, dizziness or slow-thinking. “There’s no current dedicated migraine prevention medication,” says Dr. Michael R. Silver, an assistant professor in neurology at Emory University. “We borrow from other fields and use mostly anti-seizure medicines, blood pressure medicines or anti-depressants for migraine prevention.”

However, erenumabs provide promising treatment. “We’ve known CGRP have been involved in migraines for years and now, we’re finally coming out with medicines to address what is likely the root cause of migraine pain.”

Although erenumab is currently up for approval by the FDA, one downside might be the cost of having this treatment. Regardless, Dr. Silver believes that “this will hopefully usher in the new era of migraine treatment”.

Sources: American Academy of Neurology

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 09, 2020
Drug Discovery & Development
Natural Sugar Alternative Stevia May Cause Gut Bacteria Imbalance
DEC 09, 2020
Natural Sugar Alternative Stevia May Cause Gut Bacteria Imbalance
Governments are keen to create regulations to reduce sugar intake. As such, companies are increasing their usage of arti ...
DEC 20, 2020
Genetics & Genomics
A Repurposed Drug Can Treat a Genetic Disorder
DEC 20, 2020
A Repurposed Drug Can Treat a Genetic Disorder
Some researchers have sought to treat genetic diseases by correcting the mutation. But it may be possible to use another ...
DEC 09, 2020
Drug Discovery & Development
Rapid-Release Capsule for IBS
DEC 09, 2020
Rapid-Release Capsule for IBS
Researchers have developed a rapid-release capsule to treat symptoms of irritable bowel syndrome with constipation (IBS- ...
DEC 15, 2020
Drug Discovery & Development
Drug Reverses Age-Related Mental Decline
DEC 15, 2020
Drug Reverses Age-Related Mental Decline
An experimental drug, called ISRIB, has shown to reverse age-related mental decline in mice with just a few doses " ...
DEC 28, 2020
Drug Discovery & Development
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
DEC 28, 2020
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and a ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
Loading Comments...